Enjoy complimentary customisation on priority with our Enterprise License!
The preeclampsia laboratory testing market size is forecast to increase by USD 855.3 million at a CAGR of 8.09% between 2023 and 2028. The market is witnessing significant growth due to several key trends and factors. One of the primary drivers is the market expansion in emerging economies, where the incidence of preeclampsia is increasing due to rising maternal obesity and diabetes. Another trend is the growing need for companion diagnostics, which help in early detection and personalized treatment of preeclampsia. However, challenges persist in the form of a lack of awareness and limited healthcare services in developing regions, which hinder the widespread adoption of laboratory testing for preeclampsia. Despite these challenges, the market is expected to grow at a steady pace, driven by advancements in diagnostic technologies and increasing government initiatives to improve maternal health.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Test
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.